Pharmaceutical Packaging Equipment Market Updates

Global Pharmaceutical Packaging Equipment Market size was valued at USD 6 Billion in 2023 and is poised to grow from USD 6.51 Billion in 2024 to USD 11.87 Billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

Pharmaceutical packaging equipment companies should focus on providing automation in their offerings to boost their business scope. Launching new products and collaborating with different companies can also help market players expand their revenue generation potential in the long run. Developing advanced filling and wrapping machines can offer best returns for companies as per this global pharmaceutical packaging equipment market analysis in the long run. 'Robert Bosch', 'Romaco Holding', 'Marchesini Group', 'Korber AG', 'I.M.A. Industria Macchine Automatiche S.p.A.', 'Uhlmann Group', 'Accutek Packaging Equipment Companies', 'Bausch + Ströbel', 'Coesia', 'Vanguard Pharmaceuticals Equipment', 'MULTIVAC Group', 'OPTIMA Packaging Group', 'ACG Worldwide', 'BREVETTI CEA S.P.A'

Growing emphasis on sustainability around the world is forecasted to favor the global pharmaceutical packaging equipment market outlook. The need for advanced and novel equipment to reduce plastic waste and carbon emissions is expected to offer new opportunities for pharmaceutical packaging equipment companies to create new offerings in accordance with sustainability focus of pharmaceutical companies.

Development of Modular Packaging Equipment: Pharmaceutical packaging equipment companies should focus on R&D of modular and flexible machines to meet the varying demands of packaging across multiple end users. Such pharmaceutical packaging equipment can be used for a wide variety of drugs, pharmaceutical formulations, and biologics thereby further opening the application scope for pharmaceutical packaging equipment companies in the long run.

The Asia Pacific region is anticipated to account for a major chunk of the global pharmaceutical packaging equipment market share over the coming years. Growing pharmaceutical manufacturing activities, the presence of leading contract manufacturing organizations, and high investments in pharmaceutical R&D are helping this region hold sway over others.